Inventor · disambiguated record
Michael Dahm
Also filed as: DAHM MICHAEL · DAHM MICHAEL W · DAHM MICHAEL WERNER
11 granted patents·5 pending applications·213 citations·filing 1996–2022
89Inventor score
Files withDEUTSCHES KREBSFORSCH6DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS2HEXAL PHARMA GMBH2DAHM MICHAEL WERNER1HEXAL AG1
Top patents by PatentIndex Score
16 records- 0191US7456024B2Method and device for preparing a sample of biological origin in order to determine at least one constituent contained thereinHEXAL PHARMA GMBH·Filed 2002·Granted Nov 25, 2008·54 cites·6 claims
- 0288US7211433B1Method for the enriching or depleting tumor cells obtained from a body fluid and kit suitable for this purposeHEXAL GENTECH FORSCHUNGS GMBH·Filed 2000·Granted May 1, 2007·48 cites·41 claims
- 0386US10624935B2Parvovirus formulation for treating tumorsDEUTSCHES KREBSFORSCH·Filed 2017·Granted Apr 21, 2020·3 cites·12 claims
- 0480US6582904B2Method of quantifying tumour cells in a body fluid and a suitable test kitFiled 1996·Granted Jun 24, 2003·81 cites·33 claims
- 0569US11964015B2Cancer therapy with an oncolytic virus combined with a checkpoint inhibitorDEUTSCHES KREBSFORSCH·Filed 2021·Granted Apr 23, 2024·0 cites·6 claims
- 0666US11027013B2Cancer therapy with an oncolytic virus combined with a checkpoint inhibitorDEUTSCHES KREBSFORSCH·Filed 2018·Granted Jun 8, 2021·0 cites·6 claims
- 0764US12404498B2Optimized parvovirus H-1 productionDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2021·Granted Sep 2, 2025·0 cites·13 claims
- 0862US2024182907A1H-1 PV EXPRESSING RNAi EFFECTORSDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2022·Application pending·0 cites
- 0960US11324788B2Parvovirus formulation for treating tumorsDEUTSCHES KREBSFORSCH·Filed 2020·Granted May 10, 2022·0 cites·17 claims
- 1060US7323304B2Method for the immunocytological or molecular detection of disseminated tumor cells from a body fluid and kit that is suitable thereforHEXAL GENTECH FORSCHUNGSGMBH·Filed 2003·Granted Jan 29, 2008·6 cites·7 claims
- 1157US10813959B2Cancer therapy with a parvovirus combined with bevacizumabDEUTSCHES KREBSFORSCH·Filed 2016·Granted Oct 27, 2020·0 cites·9 claims
- 1257US6821726B1Method for quantitatively analyzing tumor cells in a body fluid and test kits suited thereforFiled 1999·Granted Nov 23, 2004·21 cites·50 claims
- 1357US2021060102A1Cancer therapy with a parvovirus combined with bevacizumabDEUTSCHES KREBSFORSCH·Filed 2020·Application pending·0 cites
- 1456US2009068674A1Method and device for preparing a sample of biological origin in order to determine at least one constituent contained thereinHEXAL PHARMA GMBH·Filed 2008·Application pending·0 cites
- 1553US2011212517A1Method and device for preparing a sample of biological origin in order to determine at least one constituent contained thereinDAHM MICHAEL WERNER·Filed 2011·Application pending·0 cites
- 1646US2009186341A1Receptacle for the Separation of Tumor CellsHEXAL AG·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →